Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumors × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Solid Tumors 1 Colorectal Neoplasms 1

Interventions

tivozanib 1 temsirolimus 1 Whey Proteins 1 Sunitinib 1 Paclitaxel 1 Nutrition Assessment 1 Crizotinib 1 Capecitabine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00828919 2024-12-03

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

Pfizer

Phase NA Completed

52 enrolled 12 charts

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡